Skip to content

Clinical trials

Phase 4 Hepatitis B, Chronic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 4 Country / region: South Korea Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20076
20085
20096
20102
20112
20124
20131
20141
20154
20161
20172
20184
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Unknown status11
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bukwang Pharmaceutical7
Korea University5
Yonsei University5
Asan Medical Center4
Hoffmann-La Roche3
Chong Kun Dang Pharmaceutical2
Daewoong Pharmaceutical Co. LTD.2
GlaxoSmithKline2
Samjin Pharmaceutical Co., Ltd.2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic47
Hepatitis B2
Diabetes Mellitus, Type 21
Fibrosis1
Liver Cirrhosis1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.